Health IT Analytics August 10, 2020
A precision medicine approach enhanced by artificial intelligence could lead to early autism diagnosis and intervention.
A precision medicine method enabled by artificial intelligence could lead to the first biomedical screening tool for a subtype of autism, according to a study published in Nature Medicine.
Autism affects an estimated one in 54 children in the US, researchers stated. Boys are four times more likely than girls to be diagnosed. While most children are diagnosed after age four, autism can be reliably diagnosed based on symptoms as early as age two.
Researchers studied a subtype of autism known as dyslipidemia-associated autism, which represents 6.55 percent of all diagnosed autism spectrum disorders in the US.
“Previously, autism subtypes have been defined based...
Today's Sponsors
Today's Sponsor